primer sequences Search Results


86
Eurofins primer sequences
Primer Sequences, supplied by Eurofins, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/pmc12269598__mmc6-291-0-12?v=Eurofins
Average 86 stars, based on 1 article reviews
primer sequences - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

96
Illumina Inc 812 truseq dual index sequencing primers
812 Truseq Dual Index Sequencing Primers, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/pm27738553-59-1-7?v=Illumina+Inc
Average 96 stars, based on 1 article reviews
812 truseq dual index sequencing primers - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
OriGene pcmv entry6
Pcmv Entry6, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/pmc07458815__supp_RA120__013455_159496_3_supp_559437_qd2f31-111-13-14?v=OriGene
Average 90 stars, based on 1 article reviews
pcmv entry6 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

91
OriGene u6 promoter
Fig. 1. APLP2 downregulation changes the positioning of cells in dko cortices. (A) Left: Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with <t>U6</t> driven APLP2 shRNA1, APLP2 shRNA2 or <t>control</t> <t>shRNA.</t> Right: downregulation of APLP2 normalized to the total actin (n54). (B) Confocal images of coronal slices of wild-type (WT) brains electroporated with constructs expressing APLP2 shRNA or control shRNA together with EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression does not lead to developmental differences in respect to wild-type conditions. (C) Quantification of EGFP-positive cells shown in B. Bar graphs represent frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, only 300–400 cells only are shown for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). (D) Confocal images of APP/APLP1 dko cortices transfected with APLP2 shRNA or control shRNA construct coexpressing EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression alters cortical positioning of dko cells (E) Quantification of EGFP-positive cells shown in D. Bar graphs show frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). All confocal images are maximal intensity projections of 10–15 consecutive z-sections. Upper cortical layers are stained with Cux1 antibody and DAPI is used for nuclear staining. Scale bars: 50 mm. **P,0.01, ***P,0.001.
U6 Promoter, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/pm23345401-166-21-26?v=OriGene
Average 91 stars, based on 1 article reviews
u6 promoter - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

90
OriGene turbogfp tgfp
Fig. 1. APLP2 downregulation changes the positioning of cells in dko cortices. (A) Left: Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with <t>U6</t> driven APLP2 shRNA1, APLP2 shRNA2 or <t>control</t> <t>shRNA.</t> Right: downregulation of APLP2 normalized to the total actin (n54). (B) Confocal images of coronal slices of wild-type (WT) brains electroporated with constructs expressing APLP2 shRNA or control shRNA together with EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression does not lead to developmental differences in respect to wild-type conditions. (C) Quantification of EGFP-positive cells shown in B. Bar graphs represent frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, only 300–400 cells only are shown for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). (D) Confocal images of APP/APLP1 dko cortices transfected with APLP2 shRNA or control shRNA construct coexpressing EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression alters cortical positioning of dko cells (E) Quantification of EGFP-positive cells shown in D. Bar graphs show frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). All confocal images are maximal intensity projections of 10–15 consecutive z-sections. Upper cortical layers are stained with Cux1 antibody and DAPI is used for nuclear staining. Scale bars: 50 mm. **P,0.01, ***P,0.001.
Turbogfp Tgfp, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/pm24885928-200-13-15?v=OriGene
Average 90 stars, based on 1 article reviews
turbogfp tgfp - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

91
OriGene turbo gfp orf vector
Fig. 1. APLP2 downregulation changes the positioning of cells in dko cortices. (A) Left: Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with <t>U6</t> driven APLP2 shRNA1, APLP2 shRNA2 or <t>control</t> <t>shRNA.</t> Right: downregulation of APLP2 normalized to the total actin (n54). (B) Confocal images of coronal slices of wild-type (WT) brains electroporated with constructs expressing APLP2 shRNA or control shRNA together with EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression does not lead to developmental differences in respect to wild-type conditions. (C) Quantification of EGFP-positive cells shown in B. Bar graphs represent frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, only 300–400 cells only are shown for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). (D) Confocal images of APP/APLP1 dko cortices transfected with APLP2 shRNA or control shRNA construct coexpressing EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression alters cortical positioning of dko cells (E) Quantification of EGFP-positive cells shown in D. Bar graphs show frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). All confocal images are maximal intensity projections of 10–15 consecutive z-sections. Upper cortical layers are stained with Cux1 antibody and DAPI is used for nuclear staining. Scale bars: 50 mm. **P,0.01, ***P,0.001.
Turbo Gfp Orf Vector, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/ppr0630481-361-13-15?v=OriGene
Average 91 stars, based on 1 article reviews
turbo gfp orf vector - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

91
OriGene reverse xl39 primers
Fig. 1. APLP2 downregulation changes the positioning of cells in dko cortices. (A) Left: Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with <t>U6</t> driven APLP2 shRNA1, APLP2 shRNA2 or <t>control</t> <t>shRNA.</t> Right: downregulation of APLP2 normalized to the total actin (n54). (B) Confocal images of coronal slices of wild-type (WT) brains electroporated with constructs expressing APLP2 shRNA or control shRNA together with EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression does not lead to developmental differences in respect to wild-type conditions. (C) Quantification of EGFP-positive cells shown in B. Bar graphs represent frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, only 300–400 cells only are shown for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). (D) Confocal images of APP/APLP1 dko cortices transfected with APLP2 shRNA or control shRNA construct coexpressing EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression alters cortical positioning of dko cells (E) Quantification of EGFP-positive cells shown in D. Bar graphs show frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). All confocal images are maximal intensity projections of 10–15 consecutive z-sections. Upper cortical layers are stained with Cux1 antibody and DAPI is used for nuclear staining. Scale bars: 50 mm. **P,0.01, ***P,0.001.
Reverse Xl39 Primers, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/pm29103517-81-30-34?v=OriGene
Average 91 stars, based on 1 article reviews
reverse xl39 primers - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

92
OriGene gene
Fig. 1. APLP2 downregulation changes the positioning of cells in dko cortices. (A) Left: Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with <t>U6</t> driven APLP2 shRNA1, APLP2 shRNA2 or <t>control</t> <t>shRNA.</t> Right: downregulation of APLP2 normalized to the total actin (n54). (B) Confocal images of coronal slices of wild-type (WT) brains electroporated with constructs expressing APLP2 shRNA or control shRNA together with EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression does not lead to developmental differences in respect to wild-type conditions. (C) Quantification of EGFP-positive cells shown in B. Bar graphs represent frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, only 300–400 cells only are shown for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). (D) Confocal images of APP/APLP1 dko cortices transfected with APLP2 shRNA or control shRNA construct coexpressing EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression alters cortical positioning of dko cells (E) Quantification of EGFP-positive cells shown in D. Bar graphs show frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). All confocal images are maximal intensity projections of 10–15 consecutive z-sections. Upper cortical layers are stained with Cux1 antibody and DAPI is used for nuclear staining. Scale bars: 50 mm. **P,0.01, ***P,0.001.
Gene, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/pmc11544643-59-6-10?v=OriGene
Average 92 stars, based on 1 article reviews
gene - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

93
OriGene n a pcax plppr3flag 3 n a pn1 gfp f 53 n a f syn syp gfpw viral core facility
Fig. 1. APLP2 downregulation changes the positioning of cells in dko cortices. (A) Left: Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with <t>U6</t> driven APLP2 shRNA1, APLP2 shRNA2 or <t>control</t> <t>shRNA.</t> Right: downregulation of APLP2 normalized to the total actin (n54). (B) Confocal images of coronal slices of wild-type (WT) brains electroporated with constructs expressing APLP2 shRNA or control shRNA together with EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression does not lead to developmental differences in respect to wild-type conditions. (C) Quantification of EGFP-positive cells shown in B. Bar graphs represent frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, only 300–400 cells only are shown for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). (D) Confocal images of APP/APLP1 dko cortices transfected with APLP2 shRNA or control shRNA construct coexpressing EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression alters cortical positioning of dko cells (E) Quantification of EGFP-positive cells shown in D. Bar graphs show frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). All confocal images are maximal intensity projections of 10–15 consecutive z-sections. Upper cortical layers are stained with Cux1 antibody and DAPI is used for nuclear staining. Scale bars: 50 mm. **P,0.01, ***P,0.001.
N A Pcax Plppr3flag 3 N A Pn1 Gfp F 53 N A F Syn Syp Gfpw Viral Core Facility, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/10__1016_slash_j__isci__2025__113435-418-108-107?v=OriGene
Average 93 stars, based on 1 article reviews
n a pcax plppr3flag 3 n a pn1 gfp f 53 n a f syn syp gfpw viral core facility - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

99
Complete Genomics Inc app d high throughput sequencing primer kit
Fig. 1. APLP2 downregulation changes the positioning of cells in dko cortices. (A) Left: Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with <t>U6</t> driven APLP2 shRNA1, APLP2 shRNA2 or <t>control</t> <t>shRNA.</t> Right: downregulation of APLP2 normalized to the total actin (n54). (B) Confocal images of coronal slices of wild-type (WT) brains electroporated with constructs expressing APLP2 shRNA or control shRNA together with EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression does not lead to developmental differences in respect to wild-type conditions. (C) Quantification of EGFP-positive cells shown in B. Bar graphs represent frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, only 300–400 cells only are shown for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). (D) Confocal images of APP/APLP1 dko cortices transfected with APLP2 shRNA or control shRNA construct coexpressing EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression alters cortical positioning of dko cells (E) Quantification of EGFP-positive cells shown in D. Bar graphs show frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). All confocal images are maximal intensity projections of 10–15 consecutive z-sections. Upper cortical layers are stained with Cux1 antibody and DAPI is used for nuclear staining. Scale bars: 50 mm. **P,0.01, ***P,0.001.
App D High Throughput Sequencing Primer Kit, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/10__3390_slash_biomedicines14040890-74-21-26?v=Complete+Genomics+Inc
Average 99 stars, based on 1 article reviews
app d high throughput sequencing primer kit - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

90
OriGene a origene clones
Fig. 1. APLP2 downregulation changes the positioning of cells in dko cortices. (A) Left: Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with <t>U6</t> driven APLP2 shRNA1, APLP2 shRNA2 or <t>control</t> <t>shRNA.</t> Right: downregulation of APLP2 normalized to the total actin (n54). (B) Confocal images of coronal slices of wild-type (WT) brains electroporated with constructs expressing APLP2 shRNA or control shRNA together with EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression does not lead to developmental differences in respect to wild-type conditions. (C) Quantification of EGFP-positive cells shown in B. Bar graphs represent frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, only 300–400 cells only are shown for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). (D) Confocal images of APP/APLP1 dko cortices transfected with APLP2 shRNA or control shRNA construct coexpressing EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression alters cortical positioning of dko cells (E) Quantification of EGFP-positive cells shown in D. Bar graphs show frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). All confocal images are maximal intensity projections of 10–15 consecutive z-sections. Upper cortical layers are stained with Cux1 antibody and DAPI is used for nuclear staining. Scale bars: 50 mm. **P,0.01, ***P,0.001.
A Origene Clones, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/10__7554_slash_elife__12626-69-5-6?v=OriGene
Average 90 stars, based on 1 article reviews
a origene clones - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Unigene rna seq results
Fig. 1. APLP2 downregulation changes the positioning of cells in dko cortices. (A) Left: Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with <t>U6</t> driven APLP2 shRNA1, APLP2 shRNA2 or <t>control</t> <t>shRNA.</t> Right: downregulation of APLP2 normalized to the total actin (n54). (B) Confocal images of coronal slices of wild-type (WT) brains electroporated with constructs expressing APLP2 shRNA or control shRNA together with EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression does not lead to developmental differences in respect to wild-type conditions. (C) Quantification of EGFP-positive cells shown in B. Bar graphs represent frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, only 300–400 cells only are shown for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). (D) Confocal images of APP/APLP1 dko cortices transfected with APLP2 shRNA or control shRNA construct coexpressing EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression alters cortical positioning of dko cells (E) Quantification of EGFP-positive cells shown in D. Bar graphs show frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). All confocal images are maximal intensity projections of 10–15 consecutive z-sections. Upper cortical layers are stained with Cux1 antibody and DAPI is used for nuclear staining. Scale bars: 50 mm. **P,0.01, ***P,0.001.
Rna Seq Results, supplied by Unigene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primer+sequences/pmc12462052-149-6-10?v=Unigene
Average 86 stars, based on 1 article reviews
rna seq results - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


Fig. 1. APLP2 downregulation changes the positioning of cells in dko cortices. (A) Left: Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with U6 driven APLP2 shRNA1, APLP2 shRNA2 or control shRNA. Right: downregulation of APLP2 normalized to the total actin (n54). (B) Confocal images of coronal slices of wild-type (WT) brains electroporated with constructs expressing APLP2 shRNA or control shRNA together with EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression does not lead to developmental differences in respect to wild-type conditions. (C) Quantification of EGFP-positive cells shown in B. Bar graphs represent frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, only 300–400 cells only are shown for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). (D) Confocal images of APP/APLP1 dko cortices transfected with APLP2 shRNA or control shRNA construct coexpressing EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression alters cortical positioning of dko cells (E) Quantification of EGFP-positive cells shown in D. Bar graphs show frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). All confocal images are maximal intensity projections of 10–15 consecutive z-sections. Upper cortical layers are stained with Cux1 antibody and DAPI is used for nuclear staining. Scale bars: 50 mm. **P,0.01, ***P,0.001.

Journal: Journal of cell science

Article Title: APLP2 regulates neuronal stem cell differentiation during cortical development.

doi: 10.1242/jcs.122440

Figure Lengend Snippet: Fig. 1. APLP2 downregulation changes the positioning of cells in dko cortices. (A) Left: Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with U6 driven APLP2 shRNA1, APLP2 shRNA2 or control shRNA. Right: downregulation of APLP2 normalized to the total actin (n54). (B) Confocal images of coronal slices of wild-type (WT) brains electroporated with constructs expressing APLP2 shRNA or control shRNA together with EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression does not lead to developmental differences in respect to wild-type conditions. (C) Quantification of EGFP-positive cells shown in B. Bar graphs represent frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, only 300–400 cells only are shown for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). (D) Confocal images of APP/APLP1 dko cortices transfected with APLP2 shRNA or control shRNA construct coexpressing EGFP, 4 days after electroporation (E14.5–E18.5). APLP2 shRNA expression alters cortical positioning of dko cells (E) Quantification of EGFP-positive cells shown in D. Bar graphs show frequency distribution of EGFP-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of cortical wall. Values represent the mean 6 s.d. (n55; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range; Mann–Whitney test). All confocal images are maximal intensity projections of 10–15 consecutive z-sections. Upper cortical layers are stained with Cux1 antibody and DAPI is used for nuclear staining. Scale bars: 50 mm. **P,0.01, ***P,0.001.

Article Snippet: The APLP2 shRNA1 (GI562807) (sequence: 59-CGATTACAATGAGGAGAATCCAACCGAAC-39), the APLP2 shRNA2 (GI562808) (sequence 59-ATGAAGGCTCTGGAATGGCAGAACAAGAC-39) and control shRNA (scrambled sequence: 59-GCACTACCAGAGCTAACTCAGATAGTACT-39) driven by the U6 promoter were obtained from Origene (Rockville, MD).

Techniques: Western Blot, Control, Expressing, Transfection, shRNA, Construct, Electroporation, MANN-WHITNEY, Staining

Fig. 3. Progenitor-specific expression of APLP2 shRNA is sufficient to retain cells in the proliferative zone of developing cortex. (A) Schematic comparison of U6-shRNA and microRNA-based shRNA. (B) Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with APLP2 shRNAmir or control shRNAmir. The downregulation obtained by the microRNA construct was about 90% and comparable to the efficiency of the U6 shRNA1 construct (see Fig. 1A). (C) Co-transfection of Ta-cherry (solid arrowheads) with BLBP-GFP using in utero electroporation (E14.5–E16.5) shows that the two promoters target different cell populations because only a very small fraction of cells coexpress mCherry and EGFP (6.12%; 150 cells, open arrowheads). (D) Confocal images (projection of 10–15 consecutive z-sections) of dko cortical slices transfected with APLP2 shRNAmir or control shRNAmir under the control of Ta promoter. Neuronal downregulation of APLP2 does not change cortical positioning. (E) Quantification of EGFP-positive cells shown in D. Bar graphs represent frequency distribution of EGFP- positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n53; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range, Mann–Whitney test). (F) Confocal images (projection of 10–15 consecutive z-sections) of dko cortical slices transfected with APLP2 shRNAmir or control shRNAmir under the control of BLBP promoter. Progenitor-specific expression of shRNA leads to retention of cells in the VZ/ SVZ. (G) Quantification of Cherry-positive cells shown in F. Bar graphs represent the frequency distribution of Cherry-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n53; Student’s t-test). The inset scatter plot compares the population distribution of Cherry-positive cells (n53, 300–400 cells; values represent the median 6 interquartile range, Mann– Whitney test). **P,0.01, ***P,0.001. Scale bars: 50 mm (C); 100 mm (D,F).

Journal: Journal of cell science

Article Title: APLP2 regulates neuronal stem cell differentiation during cortical development.

doi: 10.1242/jcs.122440

Figure Lengend Snippet: Fig. 3. Progenitor-specific expression of APLP2 shRNA is sufficient to retain cells in the proliferative zone of developing cortex. (A) Schematic comparison of U6-shRNA and microRNA-based shRNA. (B) Western blot showing protein levels of APLP2-V5 and actin (loading control) of HEK cells expressing APLP2-V5 transfected with APLP2 shRNAmir or control shRNAmir. The downregulation obtained by the microRNA construct was about 90% and comparable to the efficiency of the U6 shRNA1 construct (see Fig. 1A). (C) Co-transfection of Ta-cherry (solid arrowheads) with BLBP-GFP using in utero electroporation (E14.5–E16.5) shows that the two promoters target different cell populations because only a very small fraction of cells coexpress mCherry and EGFP (6.12%; 150 cells, open arrowheads). (D) Confocal images (projection of 10–15 consecutive z-sections) of dko cortical slices transfected with APLP2 shRNAmir or control shRNAmir under the control of Ta promoter. Neuronal downregulation of APLP2 does not change cortical positioning. (E) Quantification of EGFP-positive cells shown in D. Bar graphs represent frequency distribution of EGFP- positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n53; Student’s t-test). The inset scatter plot compares the population distribution of EGFP-positive cells (n53, 300–400 cells for clarity of graph; values represent the median 6 interquartile range, Mann–Whitney test). (F) Confocal images (projection of 10–15 consecutive z-sections) of dko cortical slices transfected with APLP2 shRNAmir or control shRNAmir under the control of BLBP promoter. Progenitor-specific expression of shRNA leads to retention of cells in the VZ/ SVZ. (G) Quantification of Cherry-positive cells shown in F. Bar graphs represent the frequency distribution of Cherry-positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical wall. Values represent the mean 6 s.d. (n53; Student’s t-test). The inset scatter plot compares the population distribution of Cherry-positive cells (n53, 300–400 cells; values represent the median 6 interquartile range, Mann– Whitney test). **P,0.01, ***P,0.001. Scale bars: 50 mm (C); 100 mm (D,F).

Article Snippet: The APLP2 shRNA1 (GI562807) (sequence: 59-CGATTACAATGAGGAGAATCCAACCGAAC-39), the APLP2 shRNA2 (GI562808) (sequence 59-ATGAAGGCTCTGGAATGGCAGAACAAGAC-39) and control shRNA (scrambled sequence: 59-GCACTACCAGAGCTAACTCAGATAGTACT-39) driven by the U6 promoter were obtained from Origene (Rockville, MD).

Techniques: Expressing, shRNA, Comparison, Western Blot, Control, Transfection, Construct, Cotransfection, In Utero, Electroporation, MANN-WHITNEY